Michael NL - Search Results

1

HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV.

Kijak GH, Janini M, Tovanabutra S, Sanders-Buell EE, Birx DL, Robb ML, Michael NL, McCutchan FE. Kijak GH, et al. Among authors: michael nl. AIDS Res Hum Retroviruses. 2007 Apr;23(4):554-7. doi: 10.1089/aid.2006.0279. AIDS Res Hum Retroviruses. 2007. PMID: 17451344

2

HIV neutralization assay using polymerase chain reaction-derived molecular signals.

Robb ML, Polonis V, Vahey M, Gartner S, Michael N, Fowler A, Redfield RR. Robb ML, et al. J Acquir Immune Defic Syndr (1988). 1992 Dec;5(12):1224-9. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1453333

3

Functional characterization of human immunodeficiency virus type 1 nef genes in patients with divergent rates of disease progression.

Michael NL, Chang G, d'Arcy LA, Tseng CJ, Birx DL, Sheppard HW. Michael NL, et al. J Virol. 1995 Nov;69(11):6758-69. doi: 10.1128/JVI.69.11.6758-6769.1995. J Virol. 1995. PMID: 7474087 Free PMC article.

4

Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction.

Salminen MO, Koch C, Sanders-Buell E, Ehrenberg PK, Michael NL, Carr JK, Burke DS, McCutchan FE. Salminen MO, et al. Among authors: michael nl. Virology. 1995 Oct 20;213(1):80-6. doi: 10.1006/viro.1995.1548. Virology. 1995. PMID: 7483282 Free article.

5

Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus.

Michael NL, Chang G, d'Arcy LA, Ehrenberg PK, Mariani R, Busch MP, Birx DL, Schwartz DH. Michael NL, et al. J Virol. 1995 Jul;69(7):4228-36. doi: 10.1128/JVI.69.7.4228-4236.1995. J Virol. 1995. PMID: 7769682 Free PMC article.

6

Human immunodeficiency virus type 1 cellular RNA load and splicing patterns predict disease progression in a longitudinally studied cohort.

Michael NL, Mo T, Merzouki A, O'Shaughnessy M, Oster C, Burke DS, Redfield RR, Birx DL, Cassol SA. Michael NL, et al. J Virol. 1995 Mar;69(3):1868-77. doi: 10.1128/JVI.69.3.1868-1877.1995. J Virol. 1995. PMID: 7853528 Free PMC article.

7

Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with a recombinant gp 160 subunit vaccine in a phase I study.

Vahey M, Birx DL, Michael NL, Burke DS, Redfield RR. Vahey M, et al. Among authors: michael nl. AIDS Res Hum Retroviruses. 1994 Jun;10(6):649-54. doi: 10.1089/aid.1994.10.649. AIDS Res Hum Retroviruses. 1994. PMID: 8074929 Clinical Trial. No abstract available.

8

Differential role of V3-specific antibodies in neutralization assays involving primary and laboratory-adapted isolates of HIV type 1.

Vancott TC, Polonis VR, Loomis LD, Michael NL, Nara PL, Birx DL. Vancott TC, et al. Among authors: michael nl. AIDS Res Hum Retroviruses. 1995 Nov;11(11):1379-91. doi: 10.1089/aid.1995.11.1379. AIDS Res Hum Retroviruses. 1995. PMID: 8573396

9

V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patients.

Michael NL, Davis KE, Loomis-Price LD, VanCott TC, Burke DS, Redfield RR, Birx DL. Michael NL, et al. AIDS. 1996 Feb;10(2):121-9. doi: 10.1097/00002030-199602000-00001. AIDS. 1996. PMID: 8838699 Clinical Trial.

10

Summary of track A: basic science.

Birx DL, VanCott T, Michael N, McNeil J, Stamatos N, Gilliam B, Davis R, Carr J, McCutchan F. Birx DL, et al. AIDS. 1996 Dec;10 Suppl 3:S85-106. AIDS. 1996. PMID: 8970716 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

462 results

Search Page

Filters